St. Margaret's Daughters: Medication Safety Failure - LA
Federal inspectors found the tube of Voltaren gel sitting openly on Resident 47's nightstand during visits on August 18 and August 19. The facility's own nurses confirmed he shouldn't have had access to any medication.
Resident 47 scored 11 on a standardized mental status test in July, indicating moderate cognitive impairment. His care records showed no physician orders for Voltaren gel. His treatment plan contained no provisions for self-administering medications or keeping drugs at his bedside.
The facility's medication logs documented that staff administered all of Resident 47's prescribed drugs during August. Yet the unauthorized gel remained within his reach.
When inspectors questioned a licensed practical nurse about the Voltaren on August 19, the nurse immediately recognized the problem. "Resident 47 should not have access to the medication Voltaren," the nurse told inspectors.
The same nurse confirmed that Resident 47 had never been assessed or approved for self-medication. Federal regulations require facilities to evaluate whether residents can safely handle their own drugs before allowing bedside access.
The Director of Nursing echoed this assessment the following morning. "Resident 47 should not have had the medication Voltaren at his bedside because he wasn't assessed and care planned to self-administer medications," the director told inspectors on August 20.
The violation emerged during a complaint investigation at St. Margaret's Daughters Home on Bienville Street. Inspectors examined four residents who had experienced accidents, finding the medication safety failure affected at least one person.
Voltaren gel contains diclofenac, a nonsteroidal anti-inflammatory drug used to treat arthritis pain. While applied topically, the medication can cause serious side effects including stomach bleeding and heart problems if used improperly or in excessive amounts.
For residents with cognitive impairment, unsupervised access to any medication poses risks. They may forget previous doses and apply medication repeatedly, or use products inappropriately due to memory problems or confusion.
The facility's own policies prohibited exactly what inspectors discovered. Resident 47's care plan specifically excluded self-medication privileges. His physician had written no orders authorizing the Voltaren gel. His electronic medication records showed staff maintained control of all his other prescriptions.
Yet somehow the arthritis gel appeared on his nightstand and remained there across multiple days. Neither nursing staff nor other facility employees removed it during routine room checks or medication rounds.
The inspection found no evidence that anyone had evaluated Resident 47's ability to safely handle medications. Such assessments typically examine factors including memory, judgment, physical dexterity, and understanding of drug instructions.
Resident 47's cognitive test score of 11 indicated significant impairment in areas crucial for medication safety. The Brief Interview for Mental Status measures orientation, attention, and memory. Scores between 8 and 12 suggest moderate cognitive problems that can affect daily functioning.
The facility's medication administration records showed careful documentation of staff-administered drugs throughout August. Nurses recorded giving Resident 47 his prescribed medications according to physician orders and facility protocols.
This documented adherence to medication procedures for his prescribed drugs made the presence of unauthorized Voltaren gel more striking. The facility maintained proper controls for some medications while allowing an unprescribed topical drug to remain accessible.
The nursing staff's immediate recognition of the problem when questioned suggested they understood the facility's medication policies. Both the licensed practical nurse and Director of Nursing clearly stated that Resident 47 should not have had bedside access to any drugs.
Inspectors classified the violation as causing minimal harm or potential for actual harm. However, the finding highlighted gaps between the facility's written policies and actual practice in medication management.
The inspection occurred following a complaint, though the specific nature of that complaint was not detailed in the violation report. Resident 47 was among four residents examined during the investigation of accidents at the facility.
Federal regulations require nursing homes to ensure residents can safely self-administer medications before allowing independent access. Facilities must conduct proper assessments and obtain physician orders before permitting residents to keep drugs at their bedside.
St. Margaret's Daughters Home failed to follow these requirements for Resident 47, leaving a cognitively impaired man with unsupervised access to prescription medication for multiple days.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for St. Margaret's Daughters Home from 2025-08-20 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
St. Margaret's Daughters Home in NEW ORLEANS, LA was cited for violations during a health inspection on August 20, 2025.
Federal inspectors found the tube of Voltaren gel sitting openly on Resident 47's nightstand during visits on August 18 and August 19.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.